PT Siloam International Hospitals Tbk

IDX:SILO.JK

3140 (IDR) • At close October 30, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) IDR.

20232022202120202019201820172016201520142013201220112010
Revenue 11,190,5119,518,0129,381,8917,110,1247,017,9195,964,6505,848,0065,168,363.0674,144,118.3033,340,793.3722,503,599.9931,788,082.5221,259,348.5661,030,471.74
Cost of Revenue 7,545,6065,984,6235,764,9494,779,1944,818,0224,035,7954,196,8813,646,195.1172,967,571.7392,388,731.0541,844,902.0521,343,268.006925,764.461772,920.713
Gross Profit 3,644,9053,533,3893,616,9422,330,9302,199,8971,928,8551,651,1251,522,167.951,176,546.563952,062.318658,697.941444,814.516333,584.104257,551.027
Gross Profit Ratio 0.3260.3710.3860.3280.3130.3230.2820.2950.2840.2850.2630.2490.2650.25
Reseach & Development Expenses 00000000000000
General & Administrative Expenses 707,063629,160684,519440,775618,942541,708442,385430,620.295351,950.378318,686.78240,008.977140,135.26578,388.00658,749.948
Selling & Marketing Expenses 120,31987,72962,86514,18051,62549,07052,05544,759.68821,377.48416,843.18816,111.0028,860.8273,726.5292,369.65
SG&A 1,847,703716,889747,384454,955670,567590,778494,440475,379.983373,327.862335,529.968256,119.979148,996.09282,114.53561,119.599
Other Expenses -52,1571,667,3301,699,7691,332,7691,411,131-106,864-77,703-69,915.259-53,156.677-34,262.796323,893.16514,516.64-17,358.7283,255.965
Operating Expenses 1,899,8602,384,2192,447,1531,787,7242,081,6981,630,3391,354,1341,230,554.558965,324.197783,947.104580,013.144367,863.019245,056.198156,897.788
Operating Income 1,745,0451,022,3321,018,703390,59238,476191,652219,288221,698.133158,065.689133,852.41878,684.79791,468.13771,169.178103,909.205
Operating Income Ratio 0.1560.1070.1090.0550.0050.0320.0370.0430.0380.040.0310.0510.0570.101
Total Other Income Expenses Net -78,636-38,025-45,838-79,942-188,012-132,360-96,952-119,319.583-105,475.747-74,609.276-6,923.64970.084-30,787.238-7,084.324
Income Before Tax 1,666,409984,307972,865310,650-149,536166,156200,039172,293.809105,746.61993,505.93771,761.14877,021.58157,740.66893,568.915
Income Before Tax Ratio 0.1490.1030.1040.044-0.0210.0280.0340.0330.0260.0280.0290.0430.0460.091
Income Tax Expense 419,365273,926272,681185,400183,462139,76396,51873,591.84444,040.54333,799.16421,568.66125,061.97919,860.69821,695.432
Net Income 1,211,283696,495674,117116,163-332,99816,18293,56685,900.71570,396.40462,568.92949,870.41950,461.22243,740.34667,476.614
Net Income Ratio 0.1080.0730.0720.016-0.0470.0030.0160.0170.0170.0190.020.0280.0350.065
EPS 93.2770.7452.128.94-25.61.248.549.067.477.65.826.175.3517.52
EPS Diluted 92.9270.5952.028.94-25.61.248.549.067.477.65.826.175.3517.52
EBITDA 2,687,3401,856,3201,861,014890,463311,582396,170358,737308,460.62247,646.584211,734.355131,162.805126,968.44196,008.439109,855.024
EBITDA Ratio 0.240.1950.1980.1250.0440.0660.0610.060.060.0630.0520.0710.0760.107